PCOL M1.3 part 2 Flashcards
where the actions attributed
Main site
are effector binding sites within enzymes
Allosteric sites
Act on the particular site in the receptor is the pharmacological response
Neurotransmitter
- has affinity but no pharmacological response which is the contraction [No/zero Efficacy- walang ganung effect] instead it will have RELAXATION [hindi ibig sabihin walang action pag no pharmacological response ibig sabihin lang nun ay iba yung reaction/OPPOSITE yung reaction na mangyayari]
ANTAGONIST
Ex in Agonist sa Beta 1 [anong drug yung nasabi ni maam]
perfectly fits in to the receptor site [has affinity], it gives the pharmacological responsible similar to the neurotransmitter [high efficacy] = CONTRACTION of cardiac muscle
Dobutamine
Initiate cell function producing efficacy of various types
AGONIST
- depends on; affinity and effects
refers to the relative concentration required to produce a given magnitude of the effect.
Konting amount lang nakakaproduce ng mataas na response
POTENCY
- has high efficacy (full activation)
- Promote contraction
Full agonist
(intermediate efficacy) - less activation
Partial agonist
- has zero efficacy.
- bind to receptors without initiating changes.
- It usually inhibits or blocks responses caused by agonists.
- The principle of antagonism is to opposed the agonist
- Promote relaxation
Antagonist
– identify by structural non-specific
CHEMICAL ANTAGONISM
- Neutralization
- Two substances combine in solution so that the effect of the active drug is lost [– due to chemical reaction]
CHEMICAL
Explain what will happen in Neuralization chemical antagonist
Acid in the stomach = high acidity means need nya ng base to neutralized] so need nya ng antacid to neutralized / it is categolized in structural non specific
Explain what will happen in Two substances combine [Dimercaprol chelates heavy metals and thus reduces their toxicity] chemical antagonist
Mechanism involve chelation
1st substance – Dimercaprol
[reduce toxicity]
2nd substance – heavy metals
[lead to toxicity]
ex. Gold, silver, mercury, and lead
[pagpumasok ang heavy metal sa katawan mo mag lead to toxicity, while Dimercaprol reduce the toxicity]
- Antagonist effectively reduces the concentration of the active drug at its site of action
PHARMACOKINETIC antagonism
Explain what happen here Phenobarbital reduces the anticoagulant effect of warfarin by accelerating its metabolism by pharmacokinetics antagonism
Mechanism involve ADME
Phenobarbital – can opposed the anticoagulant [enzyme inducer – nagaccelerate sya ng metabolism from other substances taken currently with it]
Warfarin – has anticoagulant effect [to prevent coagulation/ hindi magkaroon ng blood cloth that will cause pagbara ng cloth especially in the heart that will lead called embolism or thrombosis]
Thrombosis – coagulation
Explain what happen here
Phenobarbital agonist
Sodium Bicarboate – antagonist
by pharmacokinetics antagonism
Phenobarbital is an acid drug result to increased CNS function
= contraction/stimulation
Sodium Bicarboate – it will alkalinize the urine
- Decreased IONIZED
We alter the excretion of phenobarbital that antagonism
Agonist and antagonist compete for the same receptor
COMPETITIVE
antagonist activity is reversed when the agonist concentration is increased
- Reversible COMPETITIVE
antagonist dissociates very slowly, or not at all, from the receptor
- Irreversible COMPETITIVE
give example and explain REVERSIBLE COMPETITIVE
- Prazosin is a reversible antagonist of alpha1-receptor
- Who ever comes first will bind to the receptor
[alpha1-receptor + NE = vasoconstriction]
[alpha1-receptor + Prazosin = vasodilation]
give example and explain IRREVERSIBLE COMPETITIVE
- Phenoxybenzamine is an irreversible antagonist of alpha1-receptor
- Who ever has a greater number will win to bind in the receptor
[ex. When the receptor is 10 tas yung Prazosin mo 5 tas 1 lang yung NE mo Mas panalo yung prazosin kasi masmarami syang na ocuupied na receptor]
Antagonist blocks at some point in the chain of events that leads to the production of a response by the agonist
NON COMPETITIVE
explain Ca++ channel blockers, Verapamil and Nifedipine, prevent the influx of Ca++ions through the cell membrane and thus block nonspecifically the contraction of smooth muscle produced by another drug it is in non competitive
- inaabangan nya yung series of event
- can also bind in the receptor but not in the active site instead it will be in the allosteric site